{name}
{subtitle}
A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults
city
~18 mi. (Bebington, United Kingdom, +11 more cities)
facility
Clatterbridge Centre for Oncology
drug
BAY2416964, +1 more drug
Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
city
~18 mi. (Bebington, United Kingdom, +3 more cities)
facility
The Clatterbridge Cancer Centre NHS Foundation Trust
drug
nivolumab, +1 more drug
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~22 mi. (Birkenhead, United Kingdom, +199 more cities)
facility
The Clatterbridge Cancer Centre NHS Foundation Trust ( Site 0757)
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
city
~24 mi. (Rhyl, United Kingdom, +92 more cities)
facility
Betsi Cadwaladr University Health Board ( Site 0447)
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~24 mi. (Liverpool, United Kingdom, +145 more cities)
facility
Clatterbridge Cancer Center NHS FT ( Site 1800)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types